Detail akcie Polyrizon Rg online

Business Summary: Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..
Financial Summary: BRIEF: For the six months ended 30 June 2025, Polyrizon Ltd revenues was not reported. Net loss applicable to common stockholders decreased 72% to $177K. Basic Earnings per Share excluding Extraordinary Items increased from -$223.15 to -$0.74.